CL097

CL097 Suppliers list
Company Name: TargetMol Chemicals Inc.
Tel: +1-781-999-5354
Email: support@targetmol.com
Products Intro: Product Name:CL097
CAS:1026249-18-2
Package:1 mg;1 mL * 10mM (in DMSO);10 mg;100 mg;200 mg;25 mg;5 mg;50 mg Remarks:REAGENT;FOR LABORATORY USE ONLY
Company Name: Aladdin Scientific
Tel: +1-+1(833)-552-7181
Email: sales@aladdinsci.com
Products Intro: Product Name:CL097
CAS:1026249-18-2
Purity:99% Package:$300.9/5mg;$450.9/10mg;$950.9/25mg;$1500.9/50mg;Bulk package Remarks:99%
Company Name: Hangzhou ChangCun Biotechnology Co., Ltd.  
Tel: 0571-; 13567100326
Email: 158848739@qq.com
Products Intro: Product Name:CL097
CAS:1026249-18-2
Purity:98%hplc Package:1g;5g;10g
Company Name: Beijing Solarbio Science & Tecnology Co., Ltd.  
Tel: 010-50973130 4009686088
Email: 3193328036@qq.com
Products Intro: Product Name:CL097
CAS:1026249-18-2
Company Name: Nanjing crow LuNing pharmaceutical technology co., LTD  
Tel: 13382066392
Email:
Products Intro: Product Name:CL097
CAS:12111-01-7
Purity:98% Package:25KG;5KG;1KG;500g
CL097 Basic information
Product Name:CL097
Synonyms:CL097;3H-Imidazo[4,5-c]quinolin-4-amine, 2-(ethoxymethyl)-;CL 097,Immunological,inhibit,Oligonucleotide,Toll-like Receptor (TLR),Peptide,TLR7,Heterocycle,modulators,Inhibitor,Reactive Oxygen Species,TLR8,CL-097
CAS:1026249-18-2
MF:C13H14N4O
MW:242.28
EINECS:
Product Categories:
Mol File:1026249-18-2.mol
CL097 Structure
CL097 Chemical Properties
storage temp. Store at -20°C
solubility DMSO : 100 mg/mL (412.75 mM; Need ultrasonic)
Safety Information
MSDS Information
CL097 Usage And Synthesis
Biological ActivityCL097, a potent TLR7/8 agonist, induces pro-inflammatory cytokines in macrophages[1]. CL097 induces NADPH oxidase priming, resulting in an increase of the fMLF-stimulated ROS production[2]. CL097 induces activation of NF-κB at 0.1 μM in TLR7 transfected HEK293 cells and at 4 μM in TLR8-transfected HEK293 cells[1].CL097 induces hyperactivation of the NADPH oxidase by stimulating the phosphorylation of p47phox on selective sites in human neutrophils and suggest that p38 MAPK, ERK1/2, protein kinase C, and Pin1 control this process. CL097 induces the phosphorylation of p47phox on specific sites and enhances fMLF-induced p47phox phosphorylation[2]. CL097 and CD40 agonist stimulation induces efficient diabetogenic Cytotoxic T lymphocyte (CTL) function in NOD mice. CL097 (5 mg/kg, s.c.) alone causes a modest specific lysis of the target peptide (~25%). However, treatment with a combination of CL097 and CD40 agonist (10 mg/kg, i.p.) results in an increase of approximately twofold in the specific lysis of the IGRP-peptide-coated targets compared with CL097 treatment alone[3].
References[1]. Cindy Patinote, et al. Agonist and antagonist ligands of toll-like receptors 7 and 8: Ingenious tools for therapeutic purposes. Eur J Med Chem. 2020 May 1;193:112238. [2]. Karama Makni-Maalej, et al. The TLR7/8 agonist CL097 primes N-formyl-methionyl-leucyl-phenylalanine-stimulated NADPH oxidase activation in human neutrophils: critical role of p47phox phosphorylation and the proline isomerase Pin1. J Immunol. 2012 Nov 1;189(9):4657-65. [3]. A S Lee, et al. Toll-like receptor 7 stimulation promotes autoimmune diabetes in the NOD mouse. Diabetologia. 2011 Jun;54(6):1407-16.
CL097 Preparation Products And Raw materials
Tag:CL097(1026249-18-2) Related Product Information